ZEVIFY Trademark

Trademark Overview


On Tuesday, April 4, 2023, a trademark application was filed for ZEVIFY with the United States Patent and Trademark Office. The USPTO has given the ZEVIFY trademark a serial number of 97872192. The federal status of this trademark filing is ABANDONED - EXPRESS as of Tuesday, September 19, 2023. This trademark is owned by Shionogi & Co., Ltd.. The ZEVIFY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of cardiovascular diseases, diabetes, obesity, cancer, endocrine disorders, hormonal diseases and disorders, urological disorders, sexual dysfunction, HIV and AIDs, central nervous systems diseases and disorders, peripheral nervous system diseases and disorders, osteoporosis, rheumatism, neurological disorders, pain, gastrointestinal disorders, respiratory diseases and disorders, allergies, bacterial disorders, viral disorders, fungal disorders, infectious diseases, inflammationn and inflammatory diseases, sepsis, immunological disorders, musculoskeletal disorders, thrombocytopenia, disease and disorders of the liver, and opioid-induced constipation; pharmaceutical preparations for treating allergic rhinitis
zevify

General Information


Serial Number97872192
Word MarkZEVIFY
Filing DateTuesday, April 4, 2023
Status601 - ABANDONED - EXPRESS
Status DateTuesday, September 19, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment and prevention of cardiovascular diseases, diabetes, obesity, cancer, endocrine disorders, hormonal diseases and disorders, urological disorders, sexual dysfunction, HIV and AIDs, central nervous systems diseases and disorders, peripheral nervous system diseases and disorders, osteoporosis, rheumatism, neurological disorders, pain, gastrointestinal disorders, respiratory diseases and disorders, allergies, bacterial disorders, viral disorders, fungal disorders, infectious diseases, inflammationn and inflammatory diseases, sepsis, immunological disorders, musculoskeletal disorders, thrombocytopenia, disease and disorders of the liver, and opioid-induced constipation; pharmaceutical preparations for treating allergic rhinitis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 10, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameShionogi & Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOsaka-shi, Osaka 541-0045
JP

Trademark Events


Event DateEvent Description
Tuesday, September 19, 2023ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT
Tuesday, September 19, 2023ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT
Tuesday, September 19, 2023ABANDONMENT - EXPRESS MAILED
Friday, August 4, 2023LETTER OF ABANDONMENT PROCESSED
Friday, August 4, 2023TEAS EXPRESS ABANDONMENT RECEIVED
Monday, July 10, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, July 10, 2023LETTER OF SUSPENSION E-MAILED
Monday, July 10, 2023SUSPENSION LETTER WRITTEN
Friday, July 7, 2023ASSIGNED TO EXAMINER
Friday, April 14, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, April 10, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 7, 2023NEW APPLICATION ENTERED